OUR BUSINESSES

As a science-focused biotechnology company, Senescence Life Sciences is applying our research to a variety of thereapies across three businesses:

SLS Nutraceuticals

SLS NUTRA

Off-the-shelf, market-ready range of nutraceutical products to improve brain health, and increase cognitive performance.

  • Focus on purity, consistency and safety.
  • Full white label services for select brands and countries.
  • Multiple formats available.
  • Robust, ongoing clinical research to support marketing and regulatory team.
VISIT OUR WEBSITE
SLS Performance

SLS PERFORMANCE

A novel formulation designed to improve reaction time, focus, spatial awareness, and combat decision fatigue experienced by athletes, eSports professionals and other neuro-intensive activities.

  • Drink formulation currently undergoing development, with expected first clinical trial in early 2020.
  • Developed by SLS Performance and world’s leading flavour company.
  • Designed as an alternative to current high sugar, high caffeine energy drinks.
WEBSITE COMING SOON
SLS Pharmaceuticals

SLS Pharmaceuticals

Pharmaceutical division focusing on developing next-generation, clinically tested medicines for the prevention and treatment of Alzheimer’s disease.

  • Drug pipeline includes a multi-therapeutic targeting cellular repair cycles upstream of β-Amyloid production.
  • Currently in pre-clinical, with first in-human trials slated for end 2020.
WEBSITE COMING SOON

SUPPORTING MARKET SUCCESS

Senescence also provides partners with support in the following areas.

Expert scientific

content support

Thoght leadership through
available neuroscience experts

Development of clinical claims
and clinical trials support for new
aspects of cognitive improvement